Enbrel and Theo-dur drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enbrel (etanercept) and Theo-dur (theophylline). Common drug interactions include inflammation among females and aphasia among males.

The phase IV clinical study analyzes what interactions people have when they take Enbrel and Theo-dur. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.

What is Theo-dur?

Theo-dur has active ingredients of theophylline. It is often used in asthma. eHealthMe is studying from 4,451 Theo-dur users. Check the latest studies of Theo-dur.



On Jul, 16, 2026

26 people who take Enbrel and Theo-dur together, and have interactions are studied.

Enbrel and Theo-dur drug interactions.

What are the common drug interactions of Enbrel and Theo-Dur, by gender? *:

female:

  1. Inflammation
  2. Insomnia (sleeplessness)
  3. Intervertebral disc protrusion (spinal disc protrusion)
  4. Intestinal perforation (complete penetration of the wall of the intestine)
  5. Joint effusion (presence of extra fluid in joint covering)
  6. Lipoma excision
  7. Menopause (end of monthly cycles in women)
  8. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  9. Neuroma (tumour of nerve tissue)
  10. Neutropenia (an abnormally low number of neutrophils)

male:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Asthenia (weakness)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  5. Loss of consciousness
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Headache (pain in head)
  8. Influenza like illness
  9. Injection site pain
  10. Nasopharyngitis (inflammation of the nasopharynx)

What are the common drug interactions of Enbrel and Theo-Dur, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  2. Osteoporosis (bones weak and more likely to break)
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Patellofemoral pain syndrome (pain in the front of the knee)
  5. Pyrexia (fever)
  6. Radicular syndrome (pain and other symptoms such as numbness, tingling and weakness in the arms or legs)
  7. Renal failure (kidney dysfunction)
  8. Retroperitoneal neoplasm (tumour between peritoneum and the posterior abdominal wall)
  9. Synovitis (inflammation of the synovial membrane)
  10. Tendon operation

50-59:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Cardiac failure congestive
  3. Cardiogenic shock (inadequate circulation of blood)
  4. Pneumonia
  5. Abdominal pain upper
  6. Blood creatine phosphokinase increased
  7. Blood creatine phosphokinase mb increased
  8. Blood lactate dehydrogenase increased
  9. Cardiac failure
  10. Cardiac index decreased

60+:

  1. Fatigue (feeling of tiredness)
  2. Chest discomfort
  3. Adenosquamous cell lung cancer stage iv (mixed cell lung cancer stage iv)
  4. Back pain
  5. Death
  6. Decreased appetite
  7. Heart rate increased
  8. Hydropneumothorax (presence of both air and fluid in the pleural space (lungs))
  9. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  10. Metastases to bone (cancer spreads to bone)

What are the existing conditions these people have? *

  1. High Blood Pressure: 8 people, 30.77%
  2. Hypersensitivity: 4 people, 15.38%
  3. Gastritis (inflammation of stomach): 4 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and Theo-dur?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Enbrel and Theo-dur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Theo-dur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enbrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Theo-dur and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on etanercept and theophylline (the active ingredients of Enbrel and Theo-dur, respectively), and Enbrel and Theo-dur (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: